Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, announced that the U.S. Food and Drug Administration (FDA) has approved DAXXIFY™ (DaxibotulinumtoxinA-lanm) for...
Read More
After the stress of the COVID-19 pandemic, a new national survey called the Inaugural...
Read More
Facial Plastic Surgeons Donate Time to Repair Facial Injuries for
Ukrainian Refugees & Soldiers
LetibotulinumtoxinA is a newly registered neuromodulator for the treatment of glabellar lines in...
Read More
Throughout October, GetHarley Clinicians can help raise money for The Pink Ribbon Foundation (Reg....
Read More
Taking a closer look at one of the leading integrated skincare brands in the world
Read More
Wendy Lewis offers an analysis of what makes patients tick
Read More
Harpar Grace International release results of Blue Light Protection Clinical Studies undertaken by iS Clinical
Read More